The other opinion: nephrotoxicity of low-dose methotrexate - a problem which does not exist

被引：0

作者：

Fiehn, C. ^{[1
]}

机构：

[1] ACURA Rheumazentrum Baden Baden, CH-76530 Baden, Switzerland

来源：

ZEITSCHRIFT FUR RHEUMATOLOGIE | 2011年 / 70卷 / 10期

关键词：

Methotrexate; Nephrotoxicity; Renal function; Dose-dependency; Non-steroidal antirheumatic agents; RHEUMATOID-ARTHRITIS; DRUG; THERAPY;

D O I：

10.1007/s00393-011-0909-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The nephrotoxicity of methotrexate (MTX) is a phenomenon which is observed in high-dose therapy for treatment of malignant diseases. Even low-dose MTX therapy for treatment of rheumatic diseases is claimed to cause impairment in renal function. The necessity to adapt the dosage of MTX therapy for renal function disorders due to other causes however has first priority. The following article describes why nephrotoxicity of low-dose MTX has no clinical relevance and why in contrast non-steroidal anti-rheumatic drugs (NSARDs) are a problematic nephrotoxic group of substances and a long-term elimination from the therapeutic armamentarium for rheumatoid arthritis (RA) should be instigated.

引用

页码：825 / 826

页数：2

共 50 条

[21] Pharmacokinetics of low-dose methotrexate in rheumatoid arthritis: Therapeutic implications [J].

Bannwarth, B ;

Pehourcq, F ;

Lequen, L .

THERAPIE, 1997, 52 (02) :129-132

[22] Lymphoproliferative disorders in rheumatoid arthritis patients on low-dose methotrexate [J].

Sibilia, J ;

Liote, F ;

Mariette, X .

REVUE DU RHUMATISME, 1998, 65 (04) :267-273

[23] RENAL EFFECTS OF LOW-DOSE METHOTREXATE IN RHEUMATOID-ARTHRITIS [J].

SEIDEMAN, P ;

MULLERSUUR, R ;

EKMAN, E .

JOURNAL OF RHEUMATOLOGY, 1993, 20 (07) :1126-1128

[24] Low-dose methotrexate: no adverse effect on bone mineral density [J].

Reactions Weekly, 2002, 916 (1) :5-5

[25] Low-Dose Methotrexate for the Prevention of Atherosclerotic Events [J].

Ridker, Paul M. ;

Everett, Brendan M. ;

Pradhan, Aruna ;

MacFadyen, Jean G. ;

Solomon, Daniel H. ;

Zaharris, Elaine ;

Mam, Virak ;

Hasan, Ahmed ;

Rosenberg, Yves ;

Iturriaga, Erin ;

Gupta, Milan ;

Tsigoulis, Michelle ;

Verma, Subodh ;

Clearfield, Michael ;

Libby, Peter ;

Goldhaber, Samuel Z. ;

Seagle, Roger ;

Ofori, Cyril ;

Saklayen, Mohammad ;

Butman, Samuel ;

Singh, Narendra ;

Le May, Michel ;

Bertrand, Olivier ;

Johnston, James ;

Paynter, Nina P. ;

Glynn, Robert J. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (08) :752-762

[26] THE USE OF LOW-DOSE METHOTREXATE IN REFRACTORY SARCOIDOSIS [J].

LOWER, EE ;

BAUGHMAN, RP .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1990, 299 (03) :153-157

[27] Fatalities after low-dose therapy with methotrexate [J].

Buschmann C. ;

Theile A. ;

Tsokos M. ;

Püschel K. ;

Schulz F. .

Rechtsmedizin, 2007, 17 (2) :89-94

[28] A case of emphysematous pyelonephritis in a patient with rheumatoid arthritis taking corticosteroid and low-dose methotrexate [J].

Watanabe, Hiroshi ;

Suzuki, Ryoma ;

Asano, Tomoyuki ;

Shio, Kiori ;

Iwadate, Haruyo ;

Kobayashi, Hiroko ;

Matsuoka, Toshimitsu ;

Aikawa, Ken ;

Ohira, Hiromasa .

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2010, 13 (02) :180-183

[29] Treatment of bullous pemphigoid with low-dose methotrexate [J].

Bohm, I ;

Bauer, R .

HAUTARZT, 1997, 48 (12) :910-914

[30] Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report [J].

Jeiziner, Chiara ;

Allemann, Samuel S. ;

Hersberger, Kurt E. ;

Schwabedissen, Henriette E. Meyer zu .

PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2022, 15 :465-475

← 1 2 3 4 5 →